![]() |
Volumn 19, Issue 1, 2001, Pages 29-39
|
Phase 1 study of N1-N11-diethylnorspermine (DENSPM) administered TID for 6 days in patients with advanced malignancies
|
Author keywords
Diethylnorspermine; Phase I study; Polyamine
|
Indexed keywords
N1,N11 DIETHYLNORSPERMINE;
SODIUM CHLORIDE;
ADULT;
ADVANCED CANCER;
AGED;
ANEMIA;
APHASIA;
ARTICLE;
ASTHENIA;
ATAXIA;
BLOOD TOXICITY;
BRAIN TOXICITY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
HUMAN;
MALE;
MAXIMUM TOLERATED DOSE;
PHASE 1 CLINICAL TRIAL;
PRIORITY JOURNAL;
SLURRED SPEECH;
VERTIGO;
ADULT;
AGED;
ANTINEOPLASTIC AGENTS;
BIOLOGICAL AVAILABILITY;
FEMALE;
HUMANS;
INFUSIONS, INTRAVENOUS;
MALE;
MAXIMUM TOLERATED DOSE;
MIDDLE AGED;
NEOPLASMS;
SPERMINE;
|
EID: 0035094510
PISSN: 01676997
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1006448516938 Document Type: Article |
Times cited : (43)
|
References (28)
|